MentionFox
Home › funding signals › Rhizome AI
Accelerator · announced

Rhizome AI (YC W26) — Agent platform for life sciences

It takes 500,000 days of office work to bring a drug to market. We want to make it 5.

Rhizome AI is a Y Combinator company in the Winter 2026 batch. Its directory entry describes it as: Agent Platform for Life Sciences. The founder listed is Chetan Mishra (Founder/CEO) (Y Combinator directory entry, January 27, 2026).

6 more companies from YC Winter 2026 ↓

Run the free check on Rhizome AI →

Sell to companies like Rhizome AI? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Rhizome AI

New accelerator entry · 2026-01-27 · the record

Winter 2026
batch
1
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchWinter 2026
Announced2026-01-27
StageEarly
StatusActive
Team size1
IndustryB2B
Sub-industryB2B
RegionsUnited States of America, America / Canada, Remote, Fully Remote
BasedNew York City, NY, USA; Remote
HiringNo
Sitehttps://rhizomeai.com/

Pitching, partnering or investing alongside them? See who really runs and owns Rhizome AI.

Free to see. No signup.

Keep reading

More on Rhizome AI and the records around it.

Also in YC Winter 2026

Same batch, B2B first.

What do you want to do with Rhizome AI?

Get the full cited report on Rhizome AI

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Rhizome AI: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

It takes 500,000 days of office work to bring a drug to market. We want to make it 5. To get there, we need agents doing most of the work. Today, our research agent is the best way to know what the FDA thinks. Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation. It’s the best because we have the best retrieval engine. We’ve tuned it on our life science-specific dataset, and we find what others miss. As more teams use Rhizome, we gain more data on what regulatory professionals actually need, which makes retrieval even better. This flywheel is how we become the retrieval engine that powers all human and agent work in life sciences. Chetan started his career as a research engineer, but quickly realized he enjoyed building more than research. He joined EvolutionaryScale as their sole founding product engineer, launching their developer-scientist platform and scaling to tens of thousands of users and billions of API calls. He was also #16 at Instabase helping banks with document processing, closing $7m as the technical closer. Agents can do magical things today, but most in life sciences only use them to edit emails. Agents are missing the context they need to 100x the number of drugs we can bring to market. Rhizome AI is focused on that critical problem.

Want the whole picture on Rhizome AI?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Rhizome AI: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Rhizome AI covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Rhizome AI: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Rhizome AI. With no account yet, you sign up free and land on the result.

On these startup lists

AI agent startups Drug discovery startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Rhizome AI: Accepted into Y Combinator Winter 2026
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-rhizome-ai
Last updated 2026-10-20
Primary record: Y Combinator directory entry
Rhizome AI (YC W26) — Agent platform for life sciences. MentionFox, 2026-10-20. https://mentionfox.com/funding/yc-rhizome-ai